These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 29761228)

  • 1. Patterns of care analysis for head & neck cancer of unknown primary site: a survey inside the German society of radiation oncology (DEGRO).
    Müller von der Grün J; Bon D; Rödel C; Balermpas P
    Strahlenther Onkol; 2018 Aug; 194(8):750-758. PubMed ID: 29761228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unknown primary head and neck squamous cell carcinoma in the era of fluorodeoxyglucose-positron emission tomography/CT and intensity-modulated radiotherapy.
    de Ridder M; Klop M; Hamming-Vrieze O; de Boer J; Jasperse B; Smit L; Vogel W; van den Brekel M; Al-Mamgani A
    Head Neck; 2017 Jul; 39(7):1382-1391. PubMed ID: 28370570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cervical lymph node metastases from unknown primary cancer: a single-institution experience with intensity-modulated radiotherapy.
    Villeneuve H; Després P; Fortin B; Filion E; Donath D; Soulières D; Guertin L; Ayad T; Christopoulos A; Nguyen-Tan PF
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1866-71. PubMed ID: 21497452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of patients diagnosed with carcinoma metastatic to the neck from an unknown primary source and treated with intensity-modulated radiation therapy.
    Kamal M; Mohamed ASR; Fuller CD; Sturgis EM; Johnson FM; Morrison WH; Gunn GB; Hutcheson KA; Phan J; Volpe S; Ng SP; Ferrarotto R; Frank SJ; Skinner HD; Rosenthal DI; Garden AS
    Cancer; 2018 Apr; 124(7):1415-1427. PubMed ID: 29338089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of care analysis for salivary gland cancer: a survey within the German Society of Radiation Oncology (DEGRO) and recommendations for daily practice.
    von der Grün J; Rödel C; Semrau S; Balermpas P; Martin D; Fietkau R; Haderlein M
    Strahlenther Onkol; 2022 Feb; 198(2):123-134. PubMed ID: 34427717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnosis and management of squamous cell carcinoma of the head and neck region with unknown primary. A survey of 167 patients].
    Issing WJ; Taleban B; Tauber S
    Laryngorhinootologie; 2003 Sep; 82(9):659-65. PubMed ID: 14517763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and toxicity of chemoradiotherapy using intensity-modulated radiotherapy for unknown primary of head and neck.
    Sher DJ; Balboni TA; Haddad RI; Norris CM; Posner MR; Wirth LJ; Goguen LA; Annino D; Tishler RB
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1405-11. PubMed ID: 21177045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methods for estimating the site of origin of locoregional recurrence in head and neck squamous cell carcinoma.
    Due AK; Vogelius IR; Aznar MC; Bentzen SM; Berthelsen AK; Korreman SS; Kristensen CA; Specht L
    Strahlenther Onkol; 2012 Aug; 188(8):671-6. PubMed ID: 22580623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total Mucosal Irradiation with Intensity-modulated Radiotherapy in Patients with Head and Neck Carcinoma of Unknown Primary: A Pooled Analysis of Two Prospective Studies.
    Richards TM; Bhide SA; Miah AB; Del Rosario L; Bodla S; Thway K; Gujral DM; Rooney KP; Schick U; McGovern T; Grove L; Newbold KL; Harrington KJ; Nutting CM
    Clin Oncol (R Coll Radiol); 2016 Sep; 28(9):e77-e84. PubMed ID: 27180092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of 18FDG-PET/CT in the management and gross tumor volume definition for radiotherapy of head and neck cancer; single institution experiences based on long-term follow-up].
    Hideghéty K; Cserháti A; Besenyi Z; Zag L; Gaál S; Együd Z; Mózes P; Szántó E; Csenki M; Rusz O; Varga Z; Dobi Á; Maráz A; Pávics L; Lengyel Z
    Magy Onkol; 2015 Jun; 59(2):103-10. PubMed ID: 26035157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation therapy in the management of head-and-neck cancer of unknown primary origin: how does the addition of concurrent chemotherapy affect the therapeutic ratio?
    Chen AM; Farwell DG; Lau DH; Li BQ; Luu Q; Donald PJ
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):346-52. PubMed ID: 20933340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
    Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inter-observer variability of clinical target volume delineation in definitive radiotherapy of neck lymph node metastases from unknown primary. A cooperative study of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) Head and Neck Group.
    Trignani M; Argenone A; Di Biase S; Musio D; Merlotti A; Ursino S; Orlandi E; Genovesi D; Bacigalupo A
    Radiol Med; 2019 Jul; 124(7):682-692. PubMed ID: 30852793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensity-modulated radiotherapy for cervical node squamous cell carcinoma metastases from unknown head-and-neck primary site: M. D. Anderson Cancer Center outcomes and patterns of failure.
    Frank SJ; Rosenthal DI; Petsuksiri J; Ang KK; Morrison WH; Weber RS; Glisson BS; Chao KS; Schwartz DL; Chronowski GM; El-Naggar AK; Garden AS
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1005-10. PubMed ID: 20207504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensity-modulated radiotherapy for head and neck cancer of unknown primary: toxicity and preliminary efficacy.
    Klem ML; Mechalakos JG; Wolden SL; Zelefsky MJ; Singh B; Kraus D; Shaha A; Shah J; Pfister DG; Lee NY
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1100-7. PubMed ID: 17980501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cervical lymph node metastases of squamous cell carcinoma from an unknown primary.
    Jereczek-Fossa BA; Jassem J; Orecchia R
    Cancer Treat Rev; 2004 Apr; 30(2):153-64. PubMed ID: 15023433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unknown primary head and neck cancer treated with intensity-modulated radiation therapy: to what extent the volume should be irradiated.
    Lu H; Yao M; Tan H
    Oral Oncol; 2009 Jun; 45(6):474-9. PubMed ID: 18804408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial experience with oropharynx-targeted radiation therapy for metastatic squamous cell carcinoma of unknown primary of the head and neck.
    Mourad WF; Hu KS; Shasha D; Concert C; Ishihara D; Lin W; Shourbaji RA; Ryniak M; Gamez ME; Lukens JN; Li Z; Culliney BE; Khorsandi AS; Tran T; Jacobson A; Manolidis S; Schantz S; Urken M; Persky MS; Harrison LB
    Anticancer Res; 2014 Jan; 34(1):243-8. PubMed ID: 24403470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neck lymph node metastases from an unknown primary tumor retrospective study and review of literature.
    Christiansen H; Hermann RM; Martin A; Nitsche M; Schmidberger H; Pradier O
    Strahlenther Onkol; 2005 Jun; 181(6):355-62. PubMed ID: 15925977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of FDG-PET on primary nodal target volume definition for head and neck carcinomas.
    van Egmond SL; Piscaer V; Janssen LM; Stegeman I; Hobbelink MG; Grolman W; Terhaard CH
    Acta Oncol; 2016; 55(9-10):1099-1106. PubMed ID: 27219720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.